Matinas BioPharma Holdings (MTNB) Shareholder's Equity (2013 - 2026)

Matinas BioPharma Holdings (MTNB) Shareholder's Equity (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Matinas BioPharma Holdings 4.60 Mn 2.15 Mn - 3.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.02 Mn
Dec 31, 2025 4.83 Mn
Sep 30, 2025 6.46 Mn
Jun 30, 2025 7.68 Mn
Mar 31, 2025 6.27 Mn
Dec 31, 2024 7.59 Mn
Sep 30, 2024 15.78 Mn
Jun 30, 2024 19.10 Mn
Mar 31, 2024 14.56 Mn
Dec 31, 2023 19.25 Mn
Sep 30, 2023 23.15 Mn
Jun 30, 2023 27.85 Mn
Mar 31, 2023 32.63 Mn
Dec 31, 2022 36.64 Mn
Sep 30, 2022 38.62 Mn
Jun 30, 2022 42.85 Mn
Mar 31, 2022 47.68 Mn
Dec 31, 2021 52.49 Mn
Sep 30, 2021 58.25 Mn
Jun 30, 2021 62.90 Mn